Thyroid dysfunction in a UK hepatitis C population treated with interferon-α and ribavirin combination therapy - Costelloe, Seán J.; Wassef, Nancy; Schulz, Josephine; Vaghijiani, Tina; Morris, Catherine; Whiting, Stephen; Thomas, Michael; Dusheiko, Geoffrey; Jacobs, Michael; Vanderpump, Mark P. J. (Clinical endocrinology (Oxford), 2010)
Keywords: Adult; Age of Onset; Antiviral Agents - administration & dosage; Antiviral Agents - adverse effects; Biological and medical sciences; Drug Therapy, Combination - adverse effects; Endocrinopathies; Female; Fundamental and applied biological sciences. Psychology; Hepatitis C - drug therapy; Hepatitis C - epidemiology; Human viral diseases; Humans; Infectious diseases; Interferon-alpha - administration & dosage; Interferon-alpha - adverse effects; Male; Medical sciences; Middle Aged; Non tumoral diseases. Target tissue resistance. Benign neoplasms; Retrospective Studies; Ribavirin - administration & dosage; Ribavirin - adverse effects; Thyroid Diseases - chemically induced; Thyroid Diseases - epidemiology; Thyroid. Thyroid axis (diseases); United Kingdom - epidemiology; Vertebrates: endocrinology; Viral diseases; Viral hepatitis; United Kingdom; Europe; Endocrinopathy; Human; Drug combination; Alpha interferon; Thyroid diseases; Hepatic disease; Ribavirin; Infection; Viral hepatitis A; Thyroid function; Viral disease; Nucleoside analog; Digestive diseases; Antiviral; Population; Combined treatment; Endocrinology; Viral hepatitis C